Clinical trialNCT04374305RecruitingPhase 2Interventional

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

SponsorScott R. Plotkin, MD, PhDEnrollment109EpendymomaMeningiomaNeurofibromatosis Type 2Non-vestibular SchwannomaVestibular Schwannoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Scott Plotkin, MD
Massachusetts General Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucla Medical Center
Los Angeles, California, United States
Phioanh (Leia) Nghiemphu, MD
Recruiting
University of Miami
Miami, Florida, United States
Christine Dinh, MD
Recruiting
Indiana University School of Medicine
Indianopolis, Indiana, United States
Steven Rhodes, MD, PhD
Not, yet, recruiting
Johns Hopkins Hospital
Baltimore, Maryland, United States
Jaishri Blakeley, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Scott Plokin, MD
Recruiting
New York University Langone Medical Center
New York, New York, United States
Kaleb Yohay, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Jun 2020
Primary completion: 1 Dec 2029
Completion: 1 Dec 2030
Last update posted: 6 May 2026
Registered enrollment: 109
Registry id: NCT04374305

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.